The China Mail - First Covid vaccine side-effect claims land in German courts

USD -
AED 3.672504
AFN 66.344071
ALL 83.58702
AMD 382.869053
ANG 1.789982
AOA 917.000367
ARS 1405.057166
AUD 1.540832
AWG 1.805
AZN 1.70397
BAM 1.691481
BBD 2.013336
BDT 122.007014
BGN 1.69079
BHD 0.374011
BIF 2943.839757
BMD 1
BND 1.3018
BOB 6.91701
BRL 5.332404
BSD 0.999615
BTN 88.59887
BWP 13.420625
BYN 3.406804
BYR 19600
BZD 2.010326
CAD 1.40485
CDF 2150.000362
CHF 0.80538
CLF 0.024066
CLP 944.120396
CNY 7.11935
CNH 7.12515
COP 3780
CRC 501.883251
CUC 1
CUP 26.5
CVE 95.363087
CZK 21.009504
DJF 177.720393
DKK 6.457204
DOP 64.223754
DZD 129.411663
EGP 46.950698
ERN 15
ETB 154.306137
EUR 0.86435
FJD 2.28425
FKP 0.760233
GBP 0.759936
GEL 2.70504
GGP 0.760233
GHS 10.930743
GIP 0.760233
GMD 73.000355
GNF 8677.076622
GTQ 7.659909
GYD 209.133877
HKD 7.77703
HNL 26.282902
HRK 6.514104
HTG 133.048509
HUF 332.660388
IDR 16685.5
ILS 3.24758
IMP 0.760233
INR 88.639504
IQD 1309.474904
IRR 42100.000352
ISK 126.580386
JEP 0.760233
JMD 160.439
JOD 0.70904
JPY 153.43504
KES 129.203801
KGS 87.450384
KHR 4023.264362
KMF 421.00035
KPW 900.018268
KRW 1455.990383
KWD 0.306904
KYD 0.83302
KZT 524.767675
LAK 21703.220673
LBP 89512.834262
LKR 304.684561
LRD 182.526573
LSL 17.315523
LTL 2.95274
LVL 0.60489
LYD 5.458091
MAD 9.265955
MDL 17.042585
MGA 4492.856402
MKD 53.206947
MMK 2099.87471
MNT 3580.787673
MOP 8.007472
MRU 39.595594
MUR 45.910378
MVR 15.405039
MWK 1733.369658
MXN 18.44605
MYR 4.176039
MZN 63.950377
NAD 17.315148
NGN 1436.000344
NIO 36.782862
NOK 10.153804
NPR 141.758018
NZD 1.777162
OMR 0.38142
PAB 0.999671
PEN 3.37342
PGK 4.220486
PHP 58.805504
PKR 282.656184
PLN 3.665615
PYG 7072.77311
QAR 3.643196
RON 4.398804
RSD 102.170373
RUB 80.869377
RWF 1452.42265
SAR 3.750713
SBD 8.230592
SCR 13.652393
SDG 600.503676
SEK 9.528504
SGD 1.301038
SHP 0.750259
SLE 23.203667
SLL 20969.499529
SOS 571.228422
SRD 38.599038
STD 20697.981008
STN 21.189281
SVC 8.746265
SYP 11056.858374
SZL 17.321588
THB 32.395038
TJS 9.226139
TMT 3.51
TND 2.954772
TOP 2.342104
TRY 42.211304
TTD 6.77604
TWD 30.981804
TZS 2455.000335
UAH 41.915651
UGX 3498.408635
UYU 39.809213
UZS 12055.19496
VES 228.194038
VND 26310
VUV 122.303025
WST 2.820887
XAF 567.301896
XAG 0.020684
XAU 0.00025
XCD 2.70255
XCG 1.801521
XDR 0.707015
XOF 567.306803
XPF 103.14423
YER 238.503589
ZAR 17.29905
ZMK 9001.203584
ZMW 22.615629
ZWL 321.999592
  • CMSD

    0.0900

    24.1

    +0.37%

  • SCS

    0.0000

    15.76

    0%

  • BCC

    -0.0900

    70.64

    -0.13%

  • NGG

    1.4600

    77.75

    +1.88%

  • JRI

    -0.0100

    13.74

    -0.07%

  • RBGPF

    -0.7800

    75.22

    -1.04%

  • GSK

    -0.4700

    46.63

    -1.01%

  • RIO

    0.0600

    69.33

    +0.09%

  • BTI

    0.3800

    54.59

    +0.7%

  • CMSC

    0.0700

    23.85

    +0.29%

  • BCE

    0.0200

    23.19

    +0.09%

  • AZN

    0.8100

    84.58

    +0.96%

  • RELX

    -1.1200

    42.27

    -2.65%

  • VOD

    0.2400

    11.58

    +2.07%

  • RYCEF

    0.0800

    14.88

    +0.54%

  • BP

    0.7600

    36.58

    +2.08%

First Covid vaccine side-effect claims land in German courts

First Covid vaccine side-effect claims land in German courts

Vaccine-maker BioNTech faced Monday its first legal claim in its home country of Germany over adverse effects allegedly suffered by some users of its Covid vaccines, more than two years after one of the world's fastest and most extensive inoculation campaigns.

Text size:

In the face of the deadly pandemic that emerged in early 2020, which prompted border closures and lockdowns that trapped millions of people in their homes, the arrival of Covid vaccines had been widely hailed as a life-saver.

But the jabs, which had been developed at breakneck speed and granted early approval for usage, are now the focus of legal procedures in several countries including France and Britain where plaintiffs argue that the vaccines harmed their health.

In Germany, a court in Hamburg was prepared to hear a case from Monday against BioNTech, which, together with US giant Pfizer, produced the first mRNA vaccine Comirnaty.

The hearing was delayed however after the claimant's lawyers put in a last-minute challenge of the judge's impartiality, and asking instead for a panel of judges to rule on the case.

In her claim, the plaintiff reported suffering effects including "pain in the upper body, swelling of the extremities, exhaustion, fatigue and sleeping disorders" after receiving the vaccine, the court said.

She is seeking 150,000 euros ($162,000) in damages and recognition that the "defendant is bound to provide material damages", the court added.

Her lawyer Thomas Ulbrich, who is also representing another 250 people in similar cases, said his clients were "all healthy" before suffering from symptoms, allegedly following their jabs.

He believes that the medical files he has on hand offer a link between the vaccines and the symptoms experienced by his clients.

- 'Rocky and long road' -

BioNTech's mRNA vaccine, a scientific breakthrough, had been granted conditional marketing authorisation as early as December 21, 2020, by the EU regulatory authority EMA.

Similar authorisation for Moderna, another mRNA vaccine maker, swiftly followed.

With fears of catching the disease running high, the vaccines were pre-ordered by governments even during their development phases, and deployment swiftly followed once regulatory authorities gave their approval.

But the new generation of inoculations also sparked a wave of vaccine sceptics questioning the safety of the jabs.

Out of 192 million jabs given in Germany, the country's medicines regulator, the Paul Ehrlich Institute, said 338,857 suspected cases of side effects were reported, including 54,879 severe reactions.

Among the worst cases, "the symptoms are very different, they vary from stroke to thrombosis to cardiac diseases", said another German lawyer, Joachim Caesar-Preller, who represents 140 clients making similar claims.

He is seeking up to one million euros in damages per case -- plus interest -- but concedes that a "rocky and long road" lies ahead in the legal battles.

- 'Not an isolated case' -

A key point for the courts is whether the side effects of the medication, when used correctly, surpass "a justifiable level according to the findings of medical science".

In other words, the effects have to be sufficiently serious to be taken into account, said Anatol Dutta, a professor at Munich University.

A claimant identified only as Kathrin K., 45, believes her symptoms are severe enough.

She said she lost a lot of weight after taking the vaccine and had to undergo several intestinal operations.

"I hate it when people tell me that I'm an isolated case," she said. "I'm not."

To address the question of causality, the courts would likely have to obtain expert advice.

Besides the legal avenue, claimants can also turn to the state for compensation for the loss of income.

More than 8,000 such applications had been made as of April, and so far about five percent have been successful, according to German media.

BioNTech told AFP that the number of liability claims made to the company is very small when compared to the number of doses it has delivered worldwide, and that each claim had to be examined individually.

"Justified liability claims would of course be met by BioNTech," it said, adding however that "no causal relationship between (the) health impairments presented and vaccination with Comirnaty has been proven" in the cases it had reviewed so far.

Another lawyer, Anja Dornhoff, advises her clients to establish a chronology and to get medical practitioners to document the development of their symptoms.

"I hope that people with post-vaccination syndromes can be taken seriously," she said.

W.Cheng--ThChM